IHC - P504S (Racemase) | Test | Sprint Diagnostic

No, fasting is not necessary for this test. It's performed on tissue samples, typically obtained through a biopsy or surgical procedure.

No specific preparation is required. The tissue sample is usually collected by a healthcare provider during a biopsy or surgical procedure.

This test is typically ordered when prostate cancer is suspected, often following a prostate-specific antigen (PSA) test or a digital rectal exam (DRE).

This test detects the presence or absence of the P504S enzyme. It aids in distinguishing prostate cancer from non-cancerous conditions of the prostate.

The frequency of this test depends on your doctor's advice and is generally conducted during the diagnostic process or when monitoring the response to treatment.

The interpretation of the P504S (Racemase) IHC test is based on the detection of the P504S enzyme rather than a numerical value. A positive result indicates the presence of P504S, which may suggest prostate cancer.

As the test is performed on tissue samples, the main precautions relate to the biopsy or surgical procedure used to obtain the sample.

P504S levels can be influenced by the presence of prostate cancer. There are no known modifiable factors affecting P504S expression.

If your P504S (Racemase) IHC test results are abnormal, it's advisable to consult a urologist or an oncologist. They can guide you on the implications of the results and the subsequent steps to take.

While P504S is primarily associated with prostate cancer, its overexpression may also be seen in other conditions. Therefore, the test result should be interpreted in conjunction with other clinical and diagnostic information.

P504S is found in various body tissues but its detection is most commonly associated with prostate cancer.

There are no specific medication restrictions before this test. However, always inform your doctor about any medications you're taking before any biopsy or surgical procedure.

No, this test requires a tissue sample usually obtained via a biopsy or surgical procedure. Therefore, it needs to be performed in a healthcare setting by a trained professional.

The P504S (Racemase) IHC test is highly specific for prostate cancer, but it should be interpreted in conjunction with other diagnostic tests and clinical findings for a comprehensive diagnosis.

The P504S (Racemase) IHC test plays a key role in the battle against prostate cancer, providing critical information that helps healthcare providers to formulate the most effective treatment plan. Always remember, your healthcare team is there to provide support and guidance throughout your journey, ensuring you receive the best care possible.